Aslani, Jack Perez .
HRN: 22-76-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2023
MUPIROCIN 2%, 15G (TUBE)
12/13/2023
12/20/2023
TOPICAL
Ample Amount
TID
Skin Infection
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes